Literature DB >> 12490568

Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.

Bin Liu1, Jau-Shyong Hong.   

Abstract

Evidence from postmortem analysis implicates the involvement of microglia in the neurodegenerative process of several degenerative neurological diseases, including Alzheimer's disease and Parkinson's disease. It remains to be determined, however, whether microglial activation plays a role in the initiation stage of disease progression or occurs merely as a response to neuronal death. Activated microglia secrete a variety of proinflammatory and neurotoxic factors that are believed to induce and/or exacerbate neurodegeneration. In this article, we summarize recent advances on the study of the role of microglia based on findings from animal and cell culture models in the pathogenesis of neurodegenerative diseases, with particular emphasis on Parkinson's disease. In addition, we also discuss novel approaches to potential therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490568     DOI: 10.1124/jpet.102.035048

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  331 in total

Review 1.  Functional plasticity of macrophages: reversible adaptation to changing microenvironments.

Authors:  Robert D Stout; Jill Suttles
Journal:  J Leukoc Biol       Date:  2004-06-24       Impact factor: 4.962

2.  Inhibition of voltage-gated proton channels by local anaesthetics in GMI-R1 rat microglia.

Authors:  Tadashi Matsuura; Takashi Mori; Megumi Hasaka; Miyuki Kuno; Junko Kawawaki; Kiyonobu Nishikawa; Toshio Narahashi; Makoto Sawada; Akira Asada
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

3.  Involvement of CLEC16A in activation of astrocytes after LPS treated.

Authors:  Xinmin Wu; Jing Li; Chun Chen; Yaohua Yan; Shengyang Jiang; Xiaohong Wu; Bai Shao; Jin Xu; Lihua Kang; Yeqing Huang; Lin Zhu; Yuhong Ji; Yilu Gao
Journal:  Neurochem Res       Date:  2011-10-15       Impact factor: 3.996

4.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 5.  Effects of neuroinflammation on the regenerative capacity of brain stem cells.

Authors:  Isabella Russo; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

6.  Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia.

Authors:  Hiroko Nomaru; Kunihiko Sakumi; Atsuhisa Katogi; Yoshinori N Ohnishi; Kosuke Kajitani; Daisuke Tsuchimoto; Eric J Nestler; Yusaku Nakabeppu
Journal:  Glia       Date:  2014-04-25       Impact factor: 7.452

7.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

8.  Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.

Authors:  Hua-Qing Liu; Wei-Yu Zhang; Xue-Ting Luo; Yang Ye; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

9.  Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.

Authors:  Serena Becchi; Alberto Buson; Jonathan Foot; Wolfgang Jarolimek; Bernard W Balleine
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

10.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.